Procarbazine: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

27 March 2024

24 March 2024

  • curprev 05:1205:12, 24 March 2024‎ Lazy talk contribs‎ 407 bytes +3‎ No edit summary
  • curprev 05:1105:11, 24 March 2024‎ Lazy talk contribs‎ 404 bytes +404‎ Created page with "{{TreatmentInfo |drug_name=Procarbazine |FDA_approval=Yes |used_for=Glioblastoma |clinical_trial_phase=Not specified |common_side_effects=Hematological toxicity, nausea, and neurological effects |OS_with=Not specified |usefulness_rating=3 |notes=Combination of Temodar and procarbazine showed a high percentage of tumor regressions, suggesting effectiveness. |category=Other Chemotherapy and Cancer Drugs"
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Procarbazine"